Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.02 USD
Change Today 0.00 / 0.00%
Volume 0.0
IVRO On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

invitro international (IVRO) Snapshot

Open
$0.02
Previous Close
$0.02
Day High
$0.02
Day Low
$0.02
52 Week High
10/16/14 - $0.03
52 Week Low
12/31/14 - $0.0052
Market Cap
252.5K
Average Volume 10 Days
5.4K
EPS TTM
$0.0002
Shares Outstanding
14.0M
EX-Date
--
P/E TM
90.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for INVITRO INTERNATIONAL (IVRO)

Related News

No related news articles were found.

invitro international (IVRO) Related Businessweek News

No Related Businessweek News Found

invitro international (IVRO) Details

InVitro International develops and commercializes test kits for non-animal testing methods. Its products include Irritection Assay System, an invitro test, which could be used to detect, rank, and predict the ocular and/or dermal irritation potential of cosmetics, consumer products, pharmaceuticals, and chemical raw materials; and Corrositex, an invitro test that determines chemical corrosivity. The company also provides customized technology services for Irritection Assay System installation and testing process, as well as independent testing laboratory services for irritancy and corrosivity testing requirements. Its products are principally used by manufacturers of surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials. The company was founded in 1985 and is headquartered in Irvine, California.

invitro international (IVRO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

invitro international (IVRO) Key Developments

InVitro International Announces Consolidated Fourth Quarter and Full Year Ended September 30, 2014; Announces Sales Results for the First Quarter of Fiscal 2015

InVitro International announced consolidated fourth quarter and full year ended September 30, 2014. For the quarter, the company reported revenues of $200,173 compared with $192,896 for the same period a year ago. Income from operations was $7,165 compared with $22,349 for the same period a year ago. Net profit was $10,999 or $0.0005 per share compared with $25,920 or $0.0012 per share for the same period a year ago. For the full year, the company reported revenues of $686,118 compared with $712,121 for the same period a year ago. Income from operations was $18,253 compared with loss from operations of $9,451 for the same period a year ago. Net profit was $27,186 or $0.0012 per share compared with $10,832 or $0.0005 per share for the same period a year ago. The company reported sales results for the first quarter of fiscal 2015. For the quarter, the company reported sales of $139,900 nearly 35% of its 2014 sales.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IVRO:US $0.02 USD 0.00

IVRO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IVRO.
View Industry Companies
 

Industry Analysis

IVRO

Industry Average

Valuation IVRO Industry Range
Price/Earnings 4.6x
Price/Sales 0.4x
Price/Book 0.6x
Price/Cash Flow 4.6x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INVITRO INTERNATIONAL, please visit www.invitrointl.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.